European Psychiatry - Volume 41 - April 2017

866 / 916

S862 25th European Congress of Psychiatry / European Psychiatry 41S (2017) S847–S910
2 Parc de Salud MAR, “Hospital del Mar”, Addiction and Drug Rehab,
Barcelona, Spain
3 AGC SM-III-SESPA Asturian Mental Health Service, Psychiatry and
Mental Health, Luarca, Spain
∗ Corresponding author.
Introduction Alcoholic hallucinosis is a rare complication of
chronic alcohol abuse and a prevalence of 0.6–0.7% in alcoholics
has been reported.
Case report A 54-year-old Indian immigrant in Barcelona was
referred for psychiatric evaluation in April 2016 by due of his
behavioral alterations. Evaluation revealed that he was apparently
asymptomatic when he come to Spain, 18 years ago. He had been
consuming alcohol since 1974 and gradually the frequency and
quantity increased to 600mL of rum daily by 1996. He complained
of hearing voices of family members, being irritable even when he
was alone and in catatonic phases. He was found to be gloomy,
reclusive, not sleeping and talking to oneself. He used to have sleep
disturbances; irritability and tremors when temporarily stopped
alcohol consumption. He presented a clinical abstinence syndrome,
with pharmacological resistance to benzodiazepine perfusion: it
was necessary to use dexmedetomidine an Alpha2-agonist with
sedative and analgesic properties. After 12 days of medical treat-
ment on UCI, he recovered from abstinence syndrome and was
transferred to psychiatryward. Blood analysis showed raised aspar-
tate amino transferase and alanine amino transferase. Computed
tomography and magnetic resonance imaging brain revealed bilat-
eral lateral ventricle enlargement with narrowing of lower end
of Aqueduct of Sylvius. He was treated with oral paliperidone.
The dose was gradually increased to 18mg/day and he responded
quickly. In the follow-up, he was abstinent from alcohol, compli-
ant with treatment and free from all kinds of hallucinations after
medication adherence and psychotherapy.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV1392
Alexithymia and alcohol use
disorders: A critical review
F. Ghali ∗, F. Fekih Romdhane , M. Mezghanni , M. Zghal , G. Jmii ,
A. Belkhiria , I. Khemiri , I. Ghazeli , R. Ridha , L. Jouini
Razi Hospital, Psychiatry, Mannouba, Tunisia
∗ Corresponding author.
Introduction Alexithymia is a multifaceted construct that was
first described by Sifneos as difficulty identifying and communi-
cating feelings, differentiating feelings and somatic sensations of
emotional arousal, a diminution of fantasy and imagination and
an externally oriented cognitive style. Between 45–67% of alcohol
dependent individuals have been identified as alexithymic.
Aims and methodology The aim of this study is to review the pub-
lished research on alexithymia and alcohol use, to present a critical
update on the relationship between alexithymia and alcohol use
disorders.
Results Research studies have shown high prevalence rates of
alexithymia in alcohol dependent populations, yet there is only pre-
liminary evidence to indicate relationships between alexithymia,
alcohol consumption and severity of alcohol problems, and lim-
ited evidence examining the different dimensions of alexithymia in
relation to alcohol dependence. Hence, the notion that alexithymia
is a vulnerability factor in the development and maintenance of
alcohol use disorders is premature. Despite limited support for a
relationship between alexithymia and alcohol dependence, sev-
eral studies have examined alexithymia in association with other
risk factors for alcohol use including attachment, depression, per-
sonality disorder traits, emotional and perceptual dependency and
suicidal ideation.
Conclusion A number of key issues need to be addressed in exam-
ining the veracity of the link between alexithymia and alcohol
dependence. Although, alexithymia is often considered a risk factor
for the development of alcohol use disorders, there is little evidence
to support this notion. Given that alexithymia may have the poten-
tial to interfere with treatment outcomes, a better understanding
of the role of alexithymia in alcohol use is needed.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV1393
Addictive behaviors among
psychiatric outpatients
L. Ghanmi ∗, K. Zitoun , I. Hachaichi , S. Hamrouni , O. Salem ,
L. Zouari , M. Maalej
1 Regional Hospital of Gabes, Psychiatry, Gabes, Tunisia
2 University Hospital Hedi Chaker, Psychiatry “C”, Sfax, Tunisia
∗ Corresponding author.
Introduction Little is known about the epidemiology of smoking
and substance use disorders (SUD) among psychiatric outpatients
in south of Tunisia.
Objective Examine the prevalence of smoking and SUD among
adult psychiatric outpatients at the regional hospital of Gabes.
Method A survey was conducted to assess the extent of alcohol
abuse, drug abuse and smoking among adult psychiatric out-
patients (n = 115), with different psychiatric diagnoses (DSM−5),
aged over 18 years, following the psychiatric department of the
regional hospital of Gabes. Data collection was done through a
semi-structured interview with the patient and a family mem-
ber + review of medical records. SUD was defined as an abuse or
dependence to alcohol or drug.
Results Smokers account for 29.6% of the patients. Smoking was
significantly higher in male patients (97.1% vs. 43.2%, P < 10−3).
Compared to nonsmokers, smokers patients had significantly more
the diagnosis of schizophrenia (64.7% vs. 35.3%, P = 0.004), a higher
level of education (52.9% vs. 32.1%, P = 0.03), a higher rate of alco-
hol (14.7% vs. 1.2%, P= 0.008) and drug use disorders (8.8% vs. 0%,
P = 0.02), and a higher rate of relapses (3.5 vs. 2, P = 0.004). Alcohol
use was noted in 6% of patients and cannabis in 4%. Patients with a
SUDhad significantlymore the diagnosis of schizophrenia (100% vs.
36.2%, P= 0.05), a higher rate of smoking (100% vs. 27.7%, P = 0.02).
Financial situation, education, marital status and age of onset of the
disease were not associated with SUD.
Conclusion Addictive behaviors are prevalent among psychiatric
outpatients. This has implications in treatment and management
of these patients.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV1394
Impact of hepatitis B (HBV)/C (HCV)
virus co-infection on the survival of
schizophrenic patients with
co-occurring substance use disorders
followed for 12 years
Y. Gimelfarb ∗ ”r Wolf Ben Tzarfati
1 AMHC, Administration, Bat Yam, Israel
2 NZMHC, Community Clinic, NZ, Israel
∗ Corresponding author.
Introduction There is no evidence on influence of HBV/HCV
co-infection on survival characteristics in population with dual dis-
orders.